Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study)

Predicting clinical progression in multiple sclerosis after six and twelve years

(2019) I. Dekker et al.   EUROPEAN JOURNAL OF NEUROLOGY

Judgment hurts: The psychological consequences of experiencing stigma in multiple sclerosis

(2018) Margaret H. Cadden et al.   SOCIAL SCIENCE & MEDICINE

Progressive multiple sclerosis, cognitive function, and quality of life

(2018) Helene Højsgaard Chow et al.   Brain and Behavior

Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23)

(2018) María L. Martínez-Ginés et al.   Multiple Sclerosis and Related Disorders

Defining active progressive multiple sclerosis

(2017) Finn Sellebjerg et al.   Multiple Sclerosis Journal

New insights into the burden and costs of multiple sclerosis in Europe

(2017) Gisela Kobelt et al.   Multiple Sclerosis Journal

Distinct cognitive impairments in different disease courses of multiple sclerosis—A systematic review and meta-analysis

(2017) Andreas Johnen et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Defining active progressive multiple sclerosis

(2017) Finn Sellebjerg et al.   Multiple Sclerosis Journal

New insights into the burden and costs of multiple sclerosis in Europe

(2017) Gisela Kobelt et al.   Multiple Sclerosis Journal

Determinants of stigma in a cohort of hellenic patients suffering from multiple sclerosis: a cross-sectional study

(2016) Maria Anagnostouli et al.   BMC Neurology

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

(2016) Fred Lublin et al.   LANCET

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes

(2016) Luis Ruano et al.   Multiple Sclerosis Journal

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes

(2016) Luis Ruano et al.   Multiple Sclerosis Journal

Work-related problems in multiple sclerosis: a literature review on its associates and determinants

(2015) Alberto Raggi et al.   DISABILITY AND REHABILITATION

Pathological mechanisms in progressive multiple sclerosis

(2015) Don H Mahad et al.   LANCET NEUROLOGY

Composite end points to assess delay of disability progression by MS treatments

(2014) J Zhang et al.   Multiple Sclerosis Journal

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale

(2013) Cynthia A. Honan et al.   DISABILITY AND REHABILITATION

Cognitive impairment differs between primary progressive and relapsing-remitting MS

(2013) A. Ruet et al.   NEUROLOGY

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries

(2012) Korinna Karampampa et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY